Table 2.
Proportion of surviving patients at multiple time points per EMC92-ISS risk group in a Kaplan-Meier analysis of the validation data (from top to bottom: 6, 12, 24, and 72 mo, respectively)
| Pooled | <65 y | ≥65 y | Relapse | |
|---|---|---|---|---|
| 6 mo | ||||
| Low risk (%) | 98 | 97 | 96 | 95 |
| Intermediate-low risk (%) | 96 | 95 | 95 | 85 |
| Intermediate-high risk (%) | 86 | 93 | 77 | 79 |
| High risk (%) | 84 | 88 | 75 | 57 |
| Total survival (%) | 92 | 94 | 87 | 83 |
| 12 mo | ||||
| Low risk (%) | 97 | 97 | 96 | 89 |
| Intermediate-low risk (%) | 87 | 93 | 91 | 54 |
| Intermediate-high risk (%) | 74 | 93 | 73 | 42 |
| High risk (%) | 67 | 72 | 56 | 57 |
| Total survival (%) | 84 | 91 | 81 | 60 |
| 24 mo | ||||
| Low risk (%) | 92 | 97 | 92 | 55 |
| Intermediate-low risk (%) | 76 | 88 | 73 | 23 |
| Intermediate-high risk (%) | 57 | 77 | 58 | 24 |
| High risk (%) | 46 | 56 | 31 | 0 |
| Total survival (%) | 72 | 84 | 67 | 30 |
| 72 mo | ||||
| Low risk (%) | 77 | 86 | 69 | — |
| Intermediate-low risk (%) | 43 | 59 | 32 | — |
| Intermediate-high risk (%) | 27 | 39 | 28 | — |
| High risk (%) | 22 | 33 | 0 | — |
| Total survival (%) | 48 | 62 | 36 |
In the left column, patient groups are pooled (n = 328). Subsequent columns show percentages for newly diagnosed patients younger than 65 y (n = 174), newly diagnosed older than 65 y (n = 90), and relapsed patients (n = 64), respectively. The 72-mo time point is not available for the last item.